Page last updated: 2024-11-07

carbodiimides

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Carbodiimides: Compounds with the general formula RN=C=NR, where R is a hydrocarbyl group. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

methanediimine : A carbodiimide in which both nitrogens are unsubstituted. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID160435
CHEMBL ID116583
CHEBI ID87623
MeSH IDM0003351

Synonyms (12)

Synonym
8EF7219C-682B-48F8-8A33-5852D4DE56BD
methanediylidenediamine
CHEMBL116583
151-51-9
methanediimine
carbodiimides
stabilisator 9000
VPKDCDLSJZCGKE-UHFFFAOYSA-N
carbodimide
DTXSID2075188
CHEBI:87623
Q27159783

Research Excerpts

Effects

Carbodiimides have been previously used to cross-link collagen in gels and in lyophilized native tissue specimens. They were not used for electrospun mats until recently. Carbodiimide have been used to study macromolecular structure and to produce immunologically active antigens.

ExcerptReferenceRelevance
"Carbodiimides have been previously used to cross-link collagen in gels and in lyophilized native tissue specimens but had not been used for electrospun mats until recently."( Cross-linking electrospun type II collagen tissue engineering scaffolds with carbodiimide in ethanol.
Barnes, CP; Bowlin, GL; Brand, DD; Pemble, CW; Simpson, DG, 2007
)
1.06
"Carbodiimides have been used to study macromolecular structure and to produce immunologically active antigens. "( Radioactive labeling of protein carboxyl groups on factor VIII: use of carbodiimides for nuclear medicine.
DeNardo, GL; DeNardo, SJ; Godin, DR; Hershgold, EJ; Krohn, KA, 1977
)
1.93

Compound-Compound Interactions

ExcerptReferenceRelevance
" The objective of this study was to determine the effectiveness of using ECDI-SPs combined with a short course of α1-antitrypsin (AAT) for induction of tolerance."( Ethylene carbodiimide-fixed donor splenocytes combined with α-1 antitrypsin induce indefinite donor-specific protection to mice cardiac allografts.
Chen, G; Chen, L; Lai, X; Ning, F; Qiu, L; Wang, C; Yu, S; Zhang, J; Zhao, Y, 2017
)
0.46
" In this study, we aimed to determine the effect of ECDI-SPs combined with a short course of cordycepin (an anti-inflammatory agent) on the long-term outcomes of mice cardiac allografts."( Ethylene carbodiimide-fixed donor splenocytes combined with cordycepin induce long-term protection to mice cardiac allografts.
Fen, N; Guanghui, L; Jiali, F; Junjie, M; Lei, Z; Lu, X; Tiantian, W; Xingqiang, L; Yuhe, G; Zheng, C; Zhongpeng, Y, 2019
)
0.51
"In etch-and-rinse bonding system, EDC combined with EWB pretreatment can improve the quality of the hybrid layer and enhance the mechanical properties of demineralized dentin matrix."( Effects of carbodiimide combined with ethanol-wet bonding pretreatment on dentin bonding properties: an
Chen, L; Guo, L; Li, S; Xu, J; You, X; Zhang, Z, 2022
)
0.72

Bioavailability

ExcerptReferenceRelevance
" The present investigation describes synthesis of LMWH-lipid conjugates and their encapsulation in phosphatidylcholine stabilized biomimetic solid lipid nanoparticles (SLNs) for LMWH's oral bioavailability enhancement."( Biomimetic solid lipid nanoparticles for oral bioavailability enhancement of low molecular weight heparin and its lipid conjugates: in vitro and in vivo evaluation.
Agrawal, GP; Paliwal, R; Paliwal, SR; Vyas, SP, 2011
)
0.37
" Plasma insulin and blood glucose levels were measured in diabetic rats and showed about four fold increases in insulin bioavailability and sustained hypoglycemic effects up to 12h of administration with VitB12-Chi-CPNPs in comparison to Chi-CPNPs."( Vitamin B12 functionalized layer by layer calcium phosphate nanoparticles: A mucoadhesive and pH responsive carrier for improved oral delivery of insulin.
Dwivedi, P; Gupta, GK; Gupta, PK; Mishra, PR; Sharma, S; Singh, A; Teja, BV; Trivedi, R; Verma, A, 2016
)
0.43
" Apart from pH responsive behavior it utilizes multiple pathways to improve the overall bioavailability of insulin including paracellular transport and receptor mediated endocytosis."( Vitamin B12 functionalized layer by layer calcium phosphate nanoparticles: A mucoadhesive and pH responsive carrier for improved oral delivery of insulin.
Dwivedi, P; Gupta, GK; Gupta, PK; Mishra, PR; Sharma, S; Singh, A; Teja, BV; Trivedi, R; Verma, A, 2016
)
0.43
" However, clinical application of AMPs is associated with poor bioavailability and toxicity."( Biomimetic amphiphilic chitosan nanoparticles: Synthesis, characterization and antimicrobial activity.
Ahmad, N; Azmi, F; Wai, LK; Wee, CE; Zin, NM, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
carbodiimideAny organonitrogen compound that consists of two primary amino groups joined to a central carbon atom via N=C linkages.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID23443Partition coefficient (logP)1985Journal of medicinal chemistry, Mar, Volume: 28, Issue:3
Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: a demonstration using Escherichia coli dihydrofolate reductase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,474)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990686 (46.54)18.7374
1990's171 (11.60)18.2507
2000's220 (14.93)29.6817
2010's310 (21.03)24.3611
2020's87 (5.90)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 57.67

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index57.67 (24.57)
Research Supply Index7.34 (2.92)
Research Growth Index4.56 (4.65)
Search Engine Demand Index99.10 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (57.67)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.07%)5.53%
Reviews40 (2.61%)6.00%
Case Studies8 (0.52%)4.05%
Observational0 (0.00%)0.25%
Other1,485 (96.81%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]